DoseFinding
New stewardship at openpharma, then two releases adding the methods MCP-Mod was missing
Comparison · Analytics
patentsview vs pharmaverseadam
A side-by-side editorial comparison of patentsview and pharmaverseadam — release velocity, themes, recent moves, and the top alternatives to consider.
patentsview vs pharmaverseadam: at a glance
What is patentsview?
Dormant for years, then rewritten wholesale when the API underneath it broke.
patentsview is an R client for the USPTO PatentsView API, and version 1.0.0 is less a feature release than a forced reconstruction: the upstream API introduced mandatory keys, renamed and re-nested its endpoints, and the package had to follow. Between 2017 and 2021 the release cadence was roughly annual and almost entirely defensive — wrapping examples so CRAN would not fail during API outages, patching URL encoding, adding throttling retries. The 1.0.0 work restores the package to parity with an API that no longer resembles the one it was written against.
What is pharmaverseadam?
pharmaverseadam is the pharmaverse's test-data mirror, and it now covers neurology.
pharmaverseadam ships pre-built ADaM datasets generated by running the admiral family's own templates, so package authors and trainers have realistic analysis data without writing derivations first. The 1.3.0 release pulls in `ADAPET`, `ADTPET` and `ADNV` from admiralneuro and an anti-drug antibody dataset from admiral itself, and regenerates everything against current versions of seven upstream packages. Variables are now ordered and grouped to ADaM IG structure.
patentsview vs pharmaverseadam: editorial side-by-side
patentsview
0.0ANALYTICS
Dormant for years, then rewritten wholesale when the API underneath it broke.
◆ Current state
patentsview is an R client for the USPTO PatentsView API, and version 1.0.0 is less a feature release than a forced reconstruction: the upstream API introduced mandatory keys, renamed and re-nested its endpoints, and the package had to follow. Between 2017 and 2021 the release cadence was roughly annual and almost entirely defensive — wrapping examples so CRAN would not fail during API outages, patching URL encoding, adding throttling retries. The 1.0.0 work restores the package to parity with an API that no longer resembles the one it was written against.
◆ Where it's heading
The arc here is a client package whose roadmap is entirely dictated by an upstream service it does not control. Every release since 0.2.0 has been reactive — HTTPS migration, throttling, encoding fixes, and now a full breaking rewrite. The one forward-looking piece is retrieve_linked_data(), which follows HATEOAS links the API now returns, meaning the package is starting to navigate the API rather than just query fixed endpoints.
◆ Prediction
Expect the next releases to be small follow-ups against the reworked API — field list refreshes and error handling for endpoints that behave differently in practice than in the documentation. The entries do not show any independent roadmap, so anything beyond that would depend on further upstream API changes.
pharmaverseadam
0.0ANALYTICS
pharmaverseadam is the pharmaverse's test-data mirror, and it now covers neurology.
◆ Current state
pharmaverseadam ships pre-built ADaM datasets generated by running the admiral family's own templates, so package authors and trainers have realistic analysis data without writing derivations first. The 1.3.0 release pulls in `ADAPET`, `ADTPET` and `ADNV` from admiralneuro and an anti-drug antibody dataset from admiral itself, and regenerates everything against current versions of seven upstream packages. Variables are now ordered and grouped to ADaM IG structure.
◆ Where it's heading
Coverage tracks the pharmaverse's own therapeutic-area expansion with a lag of one release: pediatrics arrived in 1.1.0, metabolic in 1.2.0, neurology in 1.3.0. The other consistent thread is a slow move off development versions — 1.1.0 and 1.2.0 both had to pin unreleased upstream builds to get working templates, while 1.3.0 cites released versions throughout. Reorganising the reference page by therapeutic area is the same maturation showing up in documentation.
◆ Prediction
Expect the next release to follow the established pattern — a refresh against current upstream versions plus datasets from whichever admiral therapeutic-area package reaches a stable release next.
Alternatives to patentsview and pharmaverseadam
Other Analytics products tracked by Sparkpulse, ranked by recent ship velocity. Each card links to a full editorial trajectory and lets you pivot into a head-to-head comparison with either patentsview or pharmaverseadam.
webmockr
The stubbing library added httr2 support, then spent a year cutting itself free of everything else
crul
crul took mocking back from webmockr and made it a property of the client itself
dendroNetwork
Six releases, six identical bodies — the feed carries the package abstract instead of release notes
chattr
chattr deleted every LLM integration it had written and outsourced the lot to ellmer
cloudml
Six years since the last functional change, and Google renamed the service it wraps in the release before that
See all patentsview alternatives → · See all pharmaverseadam alternatives →
Recent activity from patentsview and pharmaverseadam
Latest ship moves from both products, interleaved chronologically. ⚡ = editorial spark.
- 5mo agopharmaverseadamNeurology and anti-drug antibody datasets added
- 6mo agopatentsviewRebuilt for PatentsView's new API: keys, nested endpoints ⚡
- 11mo agopharmaverseadamMetabolic therapeutic area datasets arrive
- 1y agopharmaverseadamPediatric ADVS added in an ad-hoc refresh
- 2y agopharmaverseadam1.0 declares the dataset collection stable
- 2y agopharmaverseadamFirst release of the ADaM dataset collection
- 4y agopatentsviewMoves to HTTPS endpoints and handles API throttling
- 7y agopatentsviewVignettes dropped so CRAN builds survive API outages
- 8y agopatentsviewAPI examples wrapped in dontrun for CRAN stability
- 8y agopatentsviewcast_pv_data() converts returned columns to real types
- 9y agopatentsviewFirst release: query DSL for the PatentsView API
Frequently asked questions
What is the difference between patentsview and pharmaverseadam?
They serve adjacent needs but don't currently overlap on shipped themes. patentsview and pharmaverseadam are shipping at a similar cadence (velocity 0.0 vs 0.0, both within Sparkpulse's "active" band). See the at-a-glance table above for a side-by-side breakdown of velocity, recent sparks, and editorial themes.
Is patentsview better than pharmaverseadam?
Sparkpulse doesn't pick a winner — we score release velocity, not feature parity. patentsview and pharmaverseadam are shipping at a similar cadence (velocity 0.0 vs 0.0, both within Sparkpulse's "active" band). For your specific use case, the alternatives sections above list other Analytics products to evaluate alongside.
What are the best alternatives to patentsview?
Top patentsview alternatives in Analytics are ranked by recent ship velocity. Browse the "patentsview alternatives" section above for the current picks, or visit /alternatives/patentsview for the full list with editorial commentary on each.
What are the best alternatives to pharmaverseadam?
Top pharmaverseadam alternatives in Analytics are ranked by recent ship velocity. Browse the "pharmaverseadam alternatives" section above for the current picks, or visit /alternatives/pharmaverseadam for the full list with editorial commentary on each.